Why too many women are prescribed antibiotics for UTIs they don’t have

Millions of Women May Be Cycling Through Antibiotics for a Condition They Never Had

Ecorescuezone.com – In urology clinics across the country, a familiar pattern repeats itself: a woman walks in exhausted, having endured multiple rounds of antibiotics over months or years, each course prescribed for what was labeled a urinary tract infection. She has completed the regimen, returned to the doctor, and been sent home again with another prescription. The cycle grinds on, and the patient grows increasingly bewildered about why the symptoms refuse to stay gone.

Maria Uloko, a urologist practicing in Los Angeles, has watched this loop unfold so many times that she decided to investigate what was actually happening in those patients’ bodies. The answer, laid out in a study published in The Journal of Sexual Medicine, challenges a deeply entrenched assumption in primary care: that recurrent urinary symptoms in women almost always trace back to bacterial infection of the bladder.

What the Data Showed

Uloko and her research team pulled the medical records of 253 women who carried a diagnosis of recurrent urinary tract infection — defined clinically as at least two episodes within six months or three within a year. They examined the underlying pathology documented in each chart. The result was stark. Only 15 percent of those women showed evidence of a problem confined to the bladder or urinary tract itself. The remaining 85 percent displayed markers of hormonally driven inflammation in the vulvar region, and 75 percent exhibited pelvic floor dysfunction.

“Most of them don’t actually have UTIs, even though that’s been their diagnosis time and time again,” Uloko says. “In fact, millions of women are being treated for UTIs they may not actually have.”

The conditions identified in the majority of those charts — vulvar inflammation and pelvic floor dysfunction — produce a symptom profile that is virtually indistinguishable from a true bacterial UTI: burning during urination, sudden urgency, increased frequency, and lower abdominal discomfort. Without careful differential diagnosis, a clinician cannot tell the two apart from symptoms alone.

Why the Misdiagnosis Persists

Part of the problem is structural. When a patient presents with classic urinary complaints, the standard first-line test ordered in most offices is a urinalysis. That test detects inflammation in the urine sample; it does not identify bacteria. Confirming a true infection requires a urine culture, which in turn demands a properly collected “clean catch” specimen — a midstream sample gathered after thorough cleansing of the urethral opening and surrounding tissue. Not every patient receives clear instruction on how to perform that collection correctly, and a contaminated sample can skew results.

Yet patients are in pain while they wait. Uloko explains that clinicians, seeing a positive urinalysis, frequently initiate a broad-spectrum antibiotic immediately and plan to adjust therapy once culture results arrive days later.

“But because patients are suffering in real time, clinicians often start them on a broad-spectrum antibiotic right away if that urinalysis comes back positive and adjust the medication if needed once the culture comes back,” Uloko says.

There is also a training gap. Medical education traditionally teaches that classic UTI symptoms should be treated as a UTI until proven otherwise. The urinalysis goes out, the culture goes out, the antibiotic starts. For patients who improve, the episode closes. For those who do not, the next visit simply restarts the same sequence.

“We do the urinalysis, send the culture, start the antibiotic, and for the patients who get better, amazing,” Uloko says. For the patients who don’t get better, the cycle continues “because the doctor, who hasn’t been taught how the vulva relates to urinary, colon, and sexual health, doesn’t know what else to do.”

The Hormonal Layer Most Clinics Overlook

Lindsey Burnett, a urogynecologist and assistant professor at the University of California San Diego who co-authored the study with Uloko, emphasizes that lower urinary tract symptoms mimicking infection can originate from entirely non-bacterial sources. One major culprit is hormonally mediated vestibulodynia — inflammation of the vulvar tissue triggered by shifts in local hormone levels.

Those shifts can arise from natural physiological transitions such as breastfeeding or menopause. They can also be iatrogenic, driven by medications that alter hormonal balance. Oral contraceptives, among the most widely prescribed anti-androgen agents, can disrupt vulvar tissue homeostasis and provoke inflammation that mimics UTI symptoms. Other commonly prescribed drugs with similar potential include isotretinoin (marketed as Accutane) for acne, minoxidil (Rogaine) for hair loss, aromatase inhibitors and selective estrogen receptor modulators used in breast, ovarian, or uterine cancer treatment, and hormonal therapies for endometriosis or uterine fibroids.

In postmenopausal women, the broader constellation known as genitourinary syndrome of menopause (GSM) — driven by declining estrogen — compounds the problem, thinning vulvar and urethral tissues and making them more susceptible to irritation and inflammation that patients interpret as infection.

What Changes Next

Melissa Kaufman, professor and chief of the division of reconstructive urology and pelvic health at Vanderbilt University Medical Center, who was not involved in the study, called the findings a potential inflection point for the specialty.

“These findings will accelerate our discipline’s investigations into a comprehensive unifying hypothesis to more precisely optimize care,” Kaufman said via e-mail.

The practical implication for patients is straightforward: if urinary symptoms persist despite repeated antibiotic courses, the question shifts from “which antibiotic next?” to “what is actually inflamed, and why?” A thorough pelvic examination, attention to hormonal status, review of current medications, and assessment of pelvic floor function become essential steps before another course of antibiotics is written. For the millions of women still caught in the loop, that reorientation — from reflexive antimicrobial therapy to a genuinely differential diagnosis — may be the single most important change in how urinary complaints are managed in the coming years.